The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 12, 2023

Filed:

May. 17, 2018
Applicant:

Idorsia Pharmaceuticals Ltd, Allschwil, CH;

Inventors:

Christoph Boss, Allschwil, CH;

Olivier Corminboeuf, Allschwil, CH;

Heinz Fretz, Gunten, CH;

Isabelle Lyothier, Allschwil, CH;

Davide Pozzi, Allschwil, CH;

Sylvia Richard-Bildstein, Allschwil, CH;

Hervé Siendt, Allschwil, CH;

Thierry Sifferlen, Allschwil, CH;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); A61K 45/06 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 239/26 (2006.01); A61K 31/505 (2006.01); C07D 405/14 (2006.01); C07D 405/12 (2006.01); C07D 413/14 (2006.01); C07D 401/14 (2006.01); A61K 31/5355 (2006.01); C07D 417/14 (2006.01); A61P 35/00 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 413/12 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 31/505 (2013.01); A61K 31/5355 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07D 239/26 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01);
Abstract

The present invention relates to pyrimidine derivatives of formula (I) wherein (R), R, R, R, R, Rand Arare as described in the description and their use in the treatment of cancer by modulating an immune response comprising a reactivation of the immune system in the tumor. The invention further relates to novel benzofurane and benzothiophene derivatives of formula (II) and their use as pharmaceuticals, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as modulators of the prostaglandin 2 receptors EP2 and/or EP4.


Find Patent Forward Citations

Loading…